Endovascular ablation of the right greater splanchnic nerve improved quality of life and exercise capacity in patients with HF with preserved ejection fraction, according to findings from a first ...

Photo Credit: Adapted from Levin H. AXON - percutaneous splanchnic nerve denervation. Presented at: THT 2022. New York, NY. The sham-controlled portion of the REBALANCE-HF trial has demonstrated that ...

For the trial, Shah and colleagues enrolled patients from a single center who underwent greater splanchnic nerve ablation (Satera; Axon Therapies) and were followed for 3 months. To be eligible for ...

Data from the first-in-human REBALANCE-HF study, presented in 2020, evaluated use of a greater splanchnic nerve ablation system (Satera, Axon Therapies) in 11 patients with chronic HFpEF and ...

Echocardiographic Findings at Baseline to 6 Months After Surgical Ablation of Right Greater Splanchnic Nerve in HFpEF. Parameters Baseline 3 Months 6 Months; E/E' 14.6: 10.7 a: 9.6 a: LV mass (g) 261: ...

Source Reference: Fudim M "Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: primary results of the REBALANCE-HF randomized trial" HFSA ...

This is an isthmic point or meeting place for all sympathetic nerves and plexuses deriving from the greater and lesser splanchnic nerves and the sympathetic trunks, which supply the stomach ...

Cite this: Hopeful Insights, No Overall HFpEF Gains From Splanchnic Nerve Ablation: REBALANCE-HF - Medscape - Oct 12, 2023. Comments 3090D553-9492-4563-8681-AD288FA52ACE ...

IN November, 1933, Max M. Peet1 performed his first splanchnic section for hypertension. The patient was an extremely sick twenty-nine-year-old man, whose blood pressure did not drop below 260 syst ...